The global hospital discharges for malignant neoplasm of the breast showed varied trends in 2023. South Korea, with the highest discharges at 116.74 thousand, saw a modest growth of 0.38%. Australia also experienced a slight increase of 0.36%, while Slovakia, Finland, Slovenia, and Sweden saw reductions, with Finland experiencing the most significant decline of 7.13%. Iceland had a notable 1.18% increase despite having the smallest value at 0.422 thousand. The last five-year CAGR highlights varied average annual changes, reflecting divergent healthcare approaches and breast cancer management strategies across these countries.
Future trends to watch include:
- Advancements in early detection and treatment methods may impact hospital discharge rates significantly.
- Population aging and lifestyle changes could influence the incidence and management of breast cancer.
- Innovations in outpatient care and telemedicine might reduce inpatient discharges over time.
- Healthcare policy changes and investment in cancer care infrastructure could drive disparities in discharge trends across countries.
Top countries in Hospital Discharges for Malignant Neoplasm of Breast by Country
| # | 9 Countries | Units (Hospital Discharges) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 South Korea | 116,740 | 2023 | +0.3% | +0.38% | View data |
| 2 | 2 Australia | 21,030 | 2023 | +0.21% | +0.36% | View data |
| 3 | 3 Slovakia | 5,020 | 2023 | -1.18% | -1.59% | View data |
| 4 | 4 Finland | 4,970 | 2023 | -7.3% | -7.13% | View data |
| 5 | 5 Norway | 3,830 | 2023 | +0.26% | -0.37% | View data |
| 6 | 6 Sweden | 3,260 | 2023 | -9.61% | -6.34% | View data |
| 7 | 7 New Zealand | 2,880 | 2023 | +0.81% | +0.4% | View data |
| 8 | 8 Slovenia | 2,570 | 2023 | +2.6% | -1.61% | View data |
| 9 | 9 Iceland | 422 | 2023 | +0.96% | +1.18% | View data |
